Jagsonpal Pharmaceuticals submits voting results of postal ballot
In continuation to its letter dated March 25, 2026, Jagsonpal Pharmaceuticals has informed that enclosed the following: a) Voting Results of Postal Ballot through remote e-voting pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 confirming that the proposed resolution for Buy- Back of Equity Shares has been passed by the Members of the Company with requisite majority. The resolution is deemed to be passed on the last date of the remote e-voting, Friday, April 24, 2026 b) Report of the Scrutinizer dated April 26, 2026 pursuant to Sections 108 & 110 of the Companies Act, 2013 and Rules 20 & 22 of the Companies (Management and Administration), Rules, 2014. The above is also being uploaded on the Company's website: https://www.jagsonpal.com/ and on the website of National Securities Depository: www.evoting.nsdl.com.
The above information is a part of company’s filings submitted to BSE.
